- LIVE QUOTES
- LEARN
- HELP
More from Webull
Our Partners
Nasdaq
Wall Street JournalEN
T
TMCI
Treace Medical Concepts, Inc.
1.89
-0.03-1.56%After Hours: 1.920 +0.030 +1.59%19:27 02/20 EST
OPEN/PREV CLOSE1.910/1.920
TODAY RANGE1.865-1.980
VOL511.54K
MARKET CAP120.43M
52 WEEK RANGE1.810-10.30
AVG VOL (3M)739.25K
% TURNOVER0.80%
TURNOVER--
P/E (TTM)-2.3786
% RANGE5.99%
EPS(TTM)-0.7946
P/E(FORWARD)-2.0214
P/B1.350
BVPS1.400
DIVIDEND--
P/S0.5632
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP87.62M
SHARES OUTSTANDING63.72M
NEXT EARNINGS02/25-03/02
FREE FLOAT46.36M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Seeking Alpha·2d ago
First Eagle Small Cap Opportunity Fund Q4 2025 Portfolio Review
Simply Wall St·02/04 19:13
Institutional owners may consider drastic measures as Treace Medical Concepts, Inc.'s (NASDAQ:TMCI) recent US$29m drop adds to long-term losses
TipRanks·01/20 14:27
Lake Street Sticks to Its Buy Rating for Treace Medical Concepts (TMCI)
TipRanks·01/13 14:34
Treace Medical Issues Preliminary Q4 Results, Highlights Growth
TipRanks·01/13 14:16
Lake Street Sticks to Its Buy Rating for Treace Medical Concepts (TMCI)
Seeking Alpha·01/13 13:40
Treace announces preliminary Q4 revenue between $62.1M to $62.5M
TipRanks·01/13 12:11
Treace Medical sees Q4 revenue $62.1M-$62.5M, consensus $61.76M
TipRanks·01/13 12:10
Treace Medical anticipates ‘continued positive procedure volume growth’
Dow Jones·01/13 12:06
*Treace Medical Concepts Sees 2025 Rev $212.3M-$212.7M >TMCI
Dow Jones·01/13 12:05
*Treace Medical Concepts Sees 4Q Rev $62.1M-$62.5M >TMCI
Same Industry
Name/Symbol
Change%
Price